COVID-19 : how effective are the repurposed drugs and novel agents in treating the infection?
المؤلفون المشاركون
Yin, Yow Hui
Suet-May, Chow
Sin-Yee, Kuok
Qing, Lee Jia
Pey-Wen, Goh
Singh, Harleen Kaur A/P Ranjit
Zhi-Zheng, Timothy Tan
Foo, Jhi-Biau
Hamzah, Sharina
Sellappans, Renukha
المصدر
Sudan Journal of Medical Sciences
العدد
المجلد 17، العدد 4 (31 ديسمبر/كانون الأول 2022)، ص ص. 498-538، 41ص.
الناشر
جامعة أم درمان الإسلامية كلية الطب
تاريخ النشر
2022-12-31
دولة النشر
السودان
عدد الصفحات
41
التخصصات الرئيسية
العلوم الطبية والصيدلة والعلوم الصحية
الملخص EN
Coronavirus disease 2019 (COVID-19) induced by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has impacted the lives and wellbeing of many people.
This globally widespread disease poses a significant public health concern that urges to discover an effective treatment.
This review paper discusses the effectiveness of repurposed drugs used to treat COVID-19 and potential novel therapies for COVID-19.
Among the various repurposed drugs, remdesivir is the only agent approved by the Food and Drug Administration (FDA) to treat COVID-19.
On the other hand, several drugs have been listed in the Emergency Use Authorization (EUA) by the FDA to treat COVID-19, including casirivimab and imdevimab, baricitinib (in combination with remdesivir), bamlanivimab, tocilizumab, and IL-6 inhibitors.
In addition, in vitro and clinical studies have suggested cepharanthine, sotrovimab, and XAV-19 as potential treatments to manage COVID-19.
Due to inadequate understanding of COVID-19 and the rapid mutation of SARS-CoV-2, COVID-19 remains a threat to global public health, with vaccination considered the most effective method to decrease COVID-19 transmission currently.
Nevertheless, with the intense efforts of clinical researchers globally, more promising treatments for COVID-19 will be established in the future.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Suet-May, Chow& Sin-Yee, Kuok& Qing, Lee Jia& Pey-Wen, Goh& Singh, Harleen Kaur A/P Ranjit& Zhi-Zheng, Timothy Tan…[et al.]. 2022. COVID-19 : how effective are the repurposed drugs and novel agents in treating the infection?. Sudan Journal of Medical Sciences،Vol. 17, no. 4, pp.498-538.
https://search.emarefa.net/detail/BIM-1491298
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Suet-May, Chow…[et al.]. COVID-19 : how effective are the repurposed drugs and novel agents in treating the infection?. Sudan Journal of Medical Sciences Vol. 17, no. 4 (2022), pp.498-538.
https://search.emarefa.net/detail/BIM-1491298
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Suet-May, Chow& Sin-Yee, Kuok& Qing, Lee Jia& Pey-Wen, Goh& Singh, Harleen Kaur A/P Ranjit& Zhi-Zheng, Timothy Tan…[et al.]. COVID-19 : how effective are the repurposed drugs and novel agents in treating the infection?. Sudan Journal of Medical Sciences. 2022. Vol. 17, no. 4, pp.498-538.
https://search.emarefa.net/detail/BIM-1491298
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Text in English ; abstracts in .
رقم السجل
BIM-1491298
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر